The presence of tumor-infiltrating CD8+ T cells has been associated with a favorable prognosis in various types of cancer (55) and CD73 deficiency is associated with a significant reduction in prostate tumor growth and increased infiltration of CD8+ T cells so CD73 may be associated with prostate cancer progression and decreased antitumor immunity (36). The gene discussed is NT5E; the disease is prostate carcinoma.